AP
REGN icon

Arlington Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Arlington Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$2.47K – 362
2023
Q3 		$2.47K Hold
3
– – ﹤0.01% 270
2023
Q2 		$2.16K Sell
3
-10
-77% -$7.71K ﹤0.01% 531
2023
Q1 		$10.7K Buy
+13
New +$9.8K ﹤0.01% 413
2022
Q1 		– Sell
-21
Closed -$13K – 615
2021
Q4 		$13K Sell
21
-78
-79% -$48K ﹤0.01% 440
2021
Q3 		$60K Buy
+99
New +$61.5K 0.02% 241
2020
Q2 		– Sell
-15
Closed -$7K – 267
2020
Q1 		$7K Buy
15
+8
+114% +$3.3K ﹤0.01% 172
2019
Q4 		$3K Buy
+7
New +$2.35K ﹤0.01% 239
2019
Q1 		– Sell
-7
Closed -$3K – 233
2018
Q4 		$3K Buy
+7
New +$2.56K ﹤0.01% 198

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return